IBRX ImmunityBio reports narrower than projected Q4 2025 per share loss while its stock holds steady for the trading session The one metric that defines Enveric Biosciences ENVB success 205 20260505 The inflation impact visible in Jackson Financial JXN results Q4 2025 Better Than Expected What Recursion Pharmaceuticals RXRX doing to improve profitability Q1 2026 Earnings Beat Estimates